Advertisement

Endocrine Disorders

Disease State Hub

Featured

Case In Point
Case In Point
02/14/2023
A 13-month-old girl presented to our clinic for a routine check-up. She was developing typically for her age but was noted to have decreasing growth velocity.
02/14/2023
Case In Point
Case In Point
02/08/2023
A 15-year-old Hispanic boy with no significant medical history presented to our pediatric emergency department with severe weakness. He was in his usual state of health the night prior to presentation but...
02/08/2023
Podcast
Podcasts360 logo
Podcast
Advertisement

Interactive Features

Endocrine disorders
Endocrine disorders
03/03/2022
Do you know the recommendations for future dosing once a growth velocity below 2.0 to 2.5 cm/year is achieved? Test your knowledge of the Pediatric Endocrine Society guidelines!
03/03/2022
Screening
Screening
11/10/2021
Clinical manifestations of adult-onset growth hormone deficiency (GHD) are nonspecific, but some clinical characteristics have been identified. Which of the following patients is most likely to have...
11/10/2021
Endocrine disorders
Endocrine disorders
11/02/2021
Growth hormone deficiency (GHD) is a clinical syndrome caused by decreased production of or decreased tissue responsiveness to growth hormone. Which of the following is the most common cause of adult-onset...
11/02/2021
Endocrine disorders
Endocrine disorders
10/28/2021
Human growth hormone deficiency can occur at any age and results from both congenital and acquired disorders. Do you know which infection might cause human growth hormone deficiency? Test your knowledge...
10/28/2021
Endocrine disorders
Endocrine disorders
11/19/2020
Calcification of the external ear cartilage is a rare diagnosis and can be related to endocrine disorders. Do you know which endocrine disorder is not associated with petrified ear?
11/19/2020

Clinical Insights

Podcast
Podcasts360 logo
Podcast
Endocrine Disorders
Podcasts360 logo
Endocrine Disorders
Expert Q&A
Expert Q&A
11/21/2022
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
11/21/2022
Endocrine Disorders
Jeffrey Levine
Endocrine Disorders